Latest filing published 14 May 2026 for Indivior Pharmaceuticals, Inc..
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Filings by Stuart A. Kingsley span 3 companies, the busiest being Indivior Pharmaceuticals, Inc., Medicines Co /DE and Scholar Rock Holding Corp. We count 5 filings; the first trade dates from 1 March 2017 and the latest from 13 May 2026.
Purchases make up the whole of the open-market record (1 purchase, €26k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 4 share grants. 2026 to date brings 1 purchase and no sales.
On 14 May 2026 came the latest disclosure, a share grant in Indivior Pharmaceuticals, Inc. The last purchase on record was published on 11 March 2026, which is 227 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations